209 related articles for article (PubMed ID: 6749685)
1. Pathogenesis of Lassa virus infection in guinea pigs.
Jahrling PB; Smith S; Hesse RA; Rhoderick JB
Infect Immun; 1982 Aug; 37(2):771-8. PubMed ID: 6749685
[TBL] [Abstract][Full Text] [Related]
2. Protection of Lassa virus-infected guinea pigs with Lassa-immune plasma of guinea pig, primate, and human origin.
Jahrling PB
J Med Virol; 1983; 12(2):93-102. PubMed ID: 6619814
[TBL] [Abstract][Full Text] [Related]
3. Lethal Infection of Lassa Virus Isolated from a Human Clinical Sample in Outbred Guinea Pigs without Adaptation.
Maruyama J; Manning JT; Mateer EJ; Sattler R; Bukreyeva N; Huang C; Paessler S
mSphere; 2019 Sep; 4(5):. PubMed ID: 31554720
[TBL] [Abstract][Full Text] [Related]
4. Temporal Progression of Lesions in Guinea Pigs Infected With Lassa Virus.
Bell TM; Shaia CI; Bearss JJ; Mattix ME; Koistinen KA; Honnold SP; Zeng X; Blancett CD; Donnelly GC; Shamblin JD; Wilkinson ER; Cashman KA
Vet Pathol; 2017 May; 54(3):549-562. PubMed ID: 28438110
[TBL] [Abstract][Full Text] [Related]
5. Virulent infection of outbred Hartley guinea pigs with recombinant Pichinde virus as a surrogate small animal model for human Lassa fever.
Lan S; Shieh WJ; Huang Q; Zaki SR; Liang Y; Ly H
Virulence; 2020 Dec; 11(1):1131-1141. PubMed ID: 32799623
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs.
Cashman KA; Wilkinson ER; Wollen SE; Shamblin JD; Zelko JM; Bearss JJ; Zeng X; Broderick KE; Schmaljohn CS
Hum Vaccin Immunother; 2017 Dec; 13(12):3010-3019. PubMed ID: 29135337
[TBL] [Abstract][Full Text] [Related]
7. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.
Safronetz D; Rosenke K; Westover JB; Martellaro C; Okumura A; Furuta Y; Geisbert J; Saturday G; Komeno T; Geisbert TW; Feldmann H; Gowen BB
Sci Rep; 2015 Oct; 5():14775. PubMed ID: 26456301
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies.
Cross RW; Mire CE; Branco LM; Geisbert JB; Rowland MM; Heinrich ML; Goba A; Momoh M; Grant DS; Fullah M; Khan SH; Robinson JE; Geisbert TW; Garry RF
Antiviral Res; 2016 Sep; 133():218-222. PubMed ID: 27531367
[TBL] [Abstract][Full Text] [Related]
9. Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay.
Niklasson BS; Jahrling PB; Peters CJ
J Clin Microbiol; 1984 Aug; 20(2):239-44. PubMed ID: 6386846
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of a pichinde virus strain adapted to produce lethal infections in guinea pigs.
Jahrling PB; Hesse RA; Rhoderick JB; Elwell MA; Moe JB
Infect Immun; 1981 May; 32(2):872-80. PubMed ID: 6265367
[TBL] [Abstract][Full Text] [Related]
11. A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.
Lukashevich IS; Patterson J; Carrion R; Moshkoff D; Ticer A; Zapata J; Brasky K; Geiger R; Hubbard GB; Bryant J; Salvato MS
J Virol; 2005 Nov; 79(22):13934-42. PubMed ID: 16254329
[TBL] [Abstract][Full Text] [Related]
12. Lassa virus antigen distribution and inflammation in the ear of infected strain 13/N Guinea pigs.
Huynh T; Gary JM; Welch SR; Coleman-McCray J; Harmon JR; Kainulainen MH; Bollweg BC; Ritter JM; Shieh WJ; Nichol ST; Zaki SR; Spiropoulou CF; Spengler JR
Antiviral Res; 2020 Nov; 183():104928. PubMed ID: 32898586
[TBL] [Abstract][Full Text] [Related]
13. A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques.
Safronetz D; Strong JE; Feldmann F; Haddock E; Sogoba N; Brining D; Geisbert TW; Scott DP; Feldmann H
J Infect Dis; 2013 Apr; 207(8):1316-27. PubMed ID: 23303805
[TBL] [Abstract][Full Text] [Related]
14. Effect of environmental factors on aerosol-induced Lassa virus infection.
Stephenson EH; Larson EW; Dominik JW
J Med Virol; 1984; 14(4):295-303. PubMed ID: 6512508
[TBL] [Abstract][Full Text] [Related]
15. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus.
Morrison HG; Bauer SP; Lange JV; Esposito JJ; McCormick JB; Auperin DD
Virology; 1989 Jul; 171(1):179-88. PubMed ID: 2741340
[TBL] [Abstract][Full Text] [Related]
16. Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization.
Jahrling PB; Frame JD; Rhoderick JB; Monson MH
Trans R Soc Trop Med Hyg; 1985; 79(3):380-4. PubMed ID: 3898484
[TBL] [Abstract][Full Text] [Related]
17. Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates.
Jahrling PB; Frame JD; Smith SB; Monson MH
Trans R Soc Trop Med Hyg; 1985; 79(3):374-9. PubMed ID: 3898483
[TBL] [Abstract][Full Text] [Related]
18. Hearing loss in outbred Hartley guinea pigs experimentally infected with Pichinde virus as a surrogate model of human mammarenaviral hemorrhagic fevers.
Brisse M; Fernández-Alarcón C; Huang Q; Kirk N; Schleiss MR; Liang Y; Ly H
Virulence; 2022 Dec; 13(1):1049-1061. PubMed ID: 35758052
[TBL] [Abstract][Full Text] [Related]
19. Persistence of Lassa Virus Associated With Severe Systemic Arteritis in Convalescing Guinea Pigs (Cavia porcellus).
Liu DX; Perry DL; DeWald LE; Cai Y; Hagen KR; Cooper TK; Huzella LM; Hart R; Bonilla A; Bernbaum JG; Janosko KB; Adams R; Johnson RF; Kuhn JH; Schnell MJ; Crozier I; Jahrling PB; de la Torre JC
J Infect Dis; 2019 May; 219(11):1818-1822. PubMed ID: 30517671
[TBL] [Abstract][Full Text] [Related]
20. Lassa Virus Replicon Particle Vaccine Protects Strain 13/N Guinea Pigs Against Challenge With Geographically and Genetically Diverse Viral Strains.
Spengler JR; Kainulainen MH; Welch SR; Coleman-McCray JD; Harmon JR; Condrey JA; Scholte FEM; Nichol ST; Montgomery JM; Albariño CG; Spiropoulou CF
J Infect Dis; 2022 Nov; 226(9):1545-1550. PubMed ID: 35099012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
